Evidence map›Paper›PMID 19074769›Full record

ArticleThe Journal of biological chemistry2009

TRPC3 activation by erythropoietin is modulated by TRPC6.

Iwona Hirschler-Laszkiewicz, Qin Tong, Kathleen Conrad, Wenyi Zhang, Wesley W Flint, Alistair J Barber, Dwayne L Barber, Joseph Y Cheung, Barbara A Miller

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. TRPC Channels and Parkinson's Disease.Advances in experimental medicine and biology · 2017
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Iwona Hirschler-LaszkiewiczDepartment of Pediatrics, the Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033, USA.
Qin Tong
Kathleen Conrad
Wenyi Zhang
Wesley W Flint
Alistair J Barber
Dwayne L Barber
Joseph Y Cheung
Barbara A Miller
Pennsylvania State University · USJefferson College · USOntario Institute for Cancer Research · CA

Funding

EXERCISE TRAINING IN POSTINFARCT HEARTR01HL058672 · NHLBI · WEIS CENTER FOR RESEARCH-GEISINGER CLINC · PI CHEUNG, JOSEPH Y · 1998 to 2012
$3.6M
Phospholemman and Cardiac ContractilityR01HL074854 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI CHEUNG, JOSEPH Y · 2005 to 2014
$2.8M
SIGNAL TRANSDUCTION MECHANISMS OF ERYTHROPOIETINR01DK046778 · NIDDK · WEIS CENTER FOR RESEARCH-GEISINGER CLINC · PI MILLER, BARBARA A. · 1994 to 2011
$2.6M
NHLBI NIH HHS R01 HL58672NHLBI NIH HHS R01 HL74854NIDDK NIH HHS R01 DK46778
6 · The paper itself

Abstract

Regulation of intracellular calcium ([Ca(2+)](i)) by erythropoietin (Epo) is an essential part of signaling pathways controlling proliferation and differentiation of erythroid progenitors, but regulatory mechanisms are largely unknown. TRPC3 and the homologous TRPC6 are two members of the transient receptor potential channel (TRPC) superfamily that are expressed on normal human erythroid precursors. Here we show that TRPC3 expression increases but TRPC6 decreases during erythroid differentiation. This is associated with a significantly greater increase in [Ca(2+)](i) in response to Epo stimulation, suggesting that the ratio of TRPC3/TRPC6 is physiologically important. In HEK 293T cells heterologously expressing TRPC and erythropoietin receptor (Epo-R), Epo stimulated an increase in [Ca(2+)](i) through TRPC3 but not TRPC6. Replacement of the C terminus of TRPC3 with the TRPC6 C terminus (TRPC3-C6C) resulted in loss of activation by Epo. In contrast, substitution of the C terminus of TRPC6 with that of TRPC3 (TRPC6-C3C) resulted in an increase in [Ca(2+)](i) in response to Epo. Substitution of the N termini had no effect. Domains in the TRPC3 C terminus between amino acids 671 and 746 are critical for the response to Epo. Epo-R and phospholipase Cgamma associated with TRPC3, and these interactions were significantly reduced with TRPC6 and TRPC3-C6C chimeras. TRPC3 and TRPC6 form heterotetramers. Coexpression of TRPC6 or C3/C6 chimeras with TRPC3 and Epo-R inhibited the Epo-stimulated increase in [Ca(2+)](i). In a heterologous expression system, Epo stimulation increased cell surface expression of TRPC3, which was inhibited by TRPC6. However, in primary erythroblasts, an increase in TRPC3 cell surface expression was not observed in erythroblasts in which Epo stimulated an increase in [Ca(2+)](i), demonstrating that increased membrane insertion of TRPC3 is not required. These data demonstrate that TRPC6 regulates TRPC3 activation by Epo. Endogenously, regulation of TRPC3 by TRPC6 may primarily be through modulation of signaling mechanisms, including reduced interaction of TRPC6 with phospholipase Cgamma and Epo-R.

Indexed as

Calcium SignalingCell DifferentiationCell LineErythroid Precursor CellsErythropoietinGene Expression RegulationHumansPhospholipase C gammaProtein Structure, QuaternaryProtein Structure, TertiaryReceptors, ErythropoietinRecombinant Fusion ProteinsTRPC6 Cation ChannelTRPC Cation ChannelsErythropoietinPhospholipase C gammaReceptors, ErythropoietinRecombinant Fusion ProteinsTRPC3 cation channelTRPC6 Cation ChannelTRPC6 protein, humanTRPC Cation Channels

Identifiers

PMID19074769
PMCPMC2640975
OpenAlexW2004646106

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.